Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 71
Journal of Biochemistry and Cell Biology received 71 citations as per Google Scholar report
Journal of Biochemistry and Cell Biology peer review process verified at publons
Indexed In
- Publons
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Dr. Jin Zhang
Principle Investigator
Department of Basic Medical Sciences
Zhejiang University
China
Biography
Dr. Jin Zhang is a Principle Investigator of Zhejiang University School of Medicine. He got his PhD from University of California, Los Angeles in 2011, and did his postdoc from 2012 to 2017 at Harvard Medical School/ Boston Children’s Hospital Stem Cell Program. He was also a scientist at Amgen Inc. and led the team to establish an iPS platform for novel drug target discovery. His current research interests are 1) the molecular mechanisms of stem cell pluripotency; 2) metabolic regulation of stem cell fate; 3) iPS disease modeling. His publication at Cell Stem Cell (2012, 2016, 2017), EMBO Journal, Nature Protocol, Cell Report, Stem Cell Report have been cited for more than 2000 times. Dr. Zhang has been awarded the National “Thousand Talent” Young Investigator Award in 2017. He has been invited to give talks at many international conferences including the International Society of Stem Cell Research 2016 Annual Meeting at San Francisco. He was also the president of the Harvard Medical School – Chinese Scholars and Scientist Association in 2014-2015.
Research Interest
Molecular mechanisms of stem cell pluripotency, Metabolic regulation of stem cell fate, iPS disease modeling
